Literature DB >> 18394557

The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.

Angeles Duran1, Juan F Linares, Anita S Galvez, Kathryn Wikenheiser, Juana M Flores, Maria T Diaz-Meco, Jorge Moscat.   

Abstract

The balance between cell death and survival, two critical aspects of oncogenic transformation, determines the outcome of tumorigenesis. Nuclear factor-kappaB (NF-kappaB) is a critical regulator of survival; it is induced by the oncogene Ras and, when inhibited, accounts for the cell death response of Ras-transformed cells. Here, we show that the signaling adaptor p62 is induced by Ras, its levels are increased in human tumors, and it is required for Ras-induced survival and transformation. p62-/- mice are resistant to Ras-induced lung adenocarcinomas. p62 is necessary for Ras to trigger IkappaB kinase (IKK) through the polyubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), and its deficiency produces increased reactive oxygen species (ROS) levels, which account for the enhanced cell death and reduced tumorigenicity of Ras in the absence of p62.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394557     DOI: 10.1016/j.ccr.2008.02.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  301 in total

1.  p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.

Authors:  Ashish Jain; Trond Lamark; Eva Sjøttem; Kenneth Bowitz Larsen; Jane Atesoh Awuh; Aud Øvervatn; Michael McMahon; John D Hayes; Terje Johansen
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

Authors:  Jianhua Ling; Ya'an Kang; Ruiying Zhao; Qianghua Xia; Dung-Fang Lee; Zhe Chang; Jin Li; Bailu Peng; Jason B Fleming; Huamin Wang; Jinsong Liu; Ihor R Lemischka; Mien-Chie Hung; Paul J Chiao
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 3.  Selective degradation of p62 by autophagy.

Authors:  Yoshinobu Ichimura; Masaaki Komatsu
Journal:  Semin Immunopathol       Date:  2010-09-03       Impact factor: 9.623

Review 4.  Selective autophagy mediated by autophagic adapter proteins.

Authors:  Terje Johansen; Trond Lamark
Journal:  Autophagy       Date:  2011-03       Impact factor: 16.016

Review 5.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

6.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

7.  p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.

Authors:  Hilaire C Lam; Christian V Baglini; Alicia Llorente Lope; Andrey A Parkhitko; Heng-Jia Liu; Nicola Alesi; Izabela A Malinowska; Darius Ebrahimi-Fakhari; Afshin Saffari; Jane J Yu; Ana Pereira; Damir Khabibullin; Barbara Ogorek; Julie Nijmeh; Taylor Kavanagh; Adam Handen; Stephen Y Chan; John M Asara; William M Oldham; Maria T Diaz-Meco; Jorge Moscat; Mustafa Sahin; Carmen Priolo; Elizabeth P Henske
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

8.  Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Sasidharan Padmaja Divya; Mei Xu; Jia Luo; Gang Chen; Zhuo Zhang; Xianglin Shi
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

9.  Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.

Authors:  Yifeng Du; Michael C Wooten; Marla Gearing; Marie W Wooten
Journal:  Free Radic Biol Med       Date:  2008-11-21       Impact factor: 7.376

10.  Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo.

Authors:  Anita S Galvez; Angeles Duran; Juan F Linares; Peterson Pathrose; Elias A Castilla; Shadi Abu-Baker; Michael Leitges; Maria T Diaz-Meco; Jorge Moscat
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.